Race Oncology Statistics

Total Valuation

Race Oncology has a market cap or net worth of AUD 247.19 million. The enterprise value is 230.00 million.

Market Cap	247.19M
Enterprise Value	230.00M

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Race Oncology has 170.47 million shares outstanding. The number of shares has increased by 2.35% in one year.

Current Share Class	n/a
Shares Outstanding	170.47M
Shares Change (YoY)	+2.35%
Shares Change (QoQ)	+1.01%
Owned by Insiders (%)	29.47%
Owned by Institutions (%)	2.61%
Float	116.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.58
PB Ratio	13.49
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.64
EV / Sales	57.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.32

Current Ratio	9.32
Quick Ratio	9.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.10% and return on invested capital (ROIC) is -41.34%.

Return on Equity (ROE)	-63.10%
Return on Assets (ROA)	-38.63%
Return on Capital (ROIC)	-41.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.83% in the last 52 weeks. The beta is 1.74, so Race Oncology's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+51.83%
50-Day Moving Average	1.56
200-Day Moving Average	1.52
Relative Strength Index (RSI)	46.22
Average Volume (20 Days)	121,323

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Race Oncology had revenue of AUD 4.00 million and -13.82 million in losses. Loss per share was -0.08.

Revenue	4.00M
Gross Profit	1.39M
Operating Income	-14.48M
Pretax Income	-13.82M
Net Income	-13.82M
EBITDA	-14.20M
EBIT	-14.48M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	17.19M
Total Debt	n/a
Net Cash	17.19M
Net Cash Per Share	0.10
Equity (Book Value)	18.31M
Book Value Per Share	0.11
Working Capital	15.55M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.55M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	34.72%
Operating Margin	-361.80%
Pretax Margin	-345.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Race Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.35%
Shareholder Yield	-2.35%
Earnings Yield	-5.79%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Race Oncology has an Altman Z-Score of 52.36.

Altman Z-Score	52.36
Piotroski F-Score	n/a